Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson’s Disease Patients

The catechol-O-methyltransferase inhibitors entacapone and opicapone prolong the efficacy of conventional oral levodopa/dopa decarboxylase inhibitor formulations through an increase in levodopa plasma bioavailability. Catechol-O-methyltransferase inhibitors influence the homocysteine metabolism asso...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Thomas Müller, Eugen Schlegel, Stephanie Zingler, Hans Michael Thiede
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-04-01
Colecção:	Cells
Assuntos:	opicapone entacapone homocysteine levodopa 3-O-methyldopa Parkinson’s disease
Acesso em linha:	https://www.mdpi.com/2073-4409/11/9/1511
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!